Lipid peroxidation: A review of causes, consequences, measurement and dietary influences

International Journal of Food Sciences and Nutrition

Volumn 47, Issue 3, 1996, Pages 233-261

  Benzie, I F F ^a  

^a HONG KONG POLYTECHNIC UNIVERSITY   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; FREE RADICAL; LIPID; MONOUNSATURATED FATTY ACID; POLYUNSATURATED FATTY ACID; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANTIOXIDANT ACTIVITY; ATHEROGENESIS; DIET; HUMAN; ISCHEMIC HEART DISEASE; LABORATORY TEST; LIPID PEROXIDATION; OXIDATIVE STRESS; REVIEW;

EID: 0029883448     PISSN: 09637486     EISSN: None     Source Type: Journal    
DOI: 10.3109/09637489609012586     Document Type: Review

References (222)

1. Ames BN (1988): Measuring oxidative damage in humans: relation to cancer and aging. IARC Sci. Publ. 89, 407-416.
2. Avogaro P, Bon GB & Cazzolato G (1988): Presence of a modified low density lipoprotein in humans. Arteriosclerosis 8, 79-87.
3. Barnett YA (1994): Nutrition and the ageing process. Br. J. Biomed. Sci. 51, 278-287.
4. Baumstark MW, Aristegui R, Zoller T, Frey I, Berg A & Keul J (1992): Probucol, incorporated into LDL particles in vivo, inhibits generation of lipid peroxidases more effectively than endogenous antioxidants alone. Clin. Biochem. 25, 395-397
5. Beckman JS, Chen J, Ischiropoulos H & Crow JP (1994): Oxiilative chemistry of peroxynitrite. In Methods in Enzymology, Vol. 233, part C: Oxygen Radicals in Biological Systems, ed. L Packer, pp. 229-240. San Diego: Academic Press.
6. Beetons JR, Coene M-C, Verheyen A, Zonnekeyn L & Herman AG (1986): Vitamin C increases prostacyclin production and decreases the vascular lesions in experimental atherosclerosis in rabbits. Prostaglandins 32, 335-352.
7. Behrens WA, Thompson JN & Madere R (1982): Distribution of alpha tocopherol in human plasma lipoproteins. Am. J. Clin. Nutr. 35, 691-696.
8. Benzie IFF (1996): An automated, specific, spectrophotometric method for measuring ascorbic acid in plasma (EFTSA). Clin. Biochem. (in press).
9. Benzie IFF & Strain JJ (1995): The effect of ascorbic acid on the measurement of total cholesterol and triglycerides: possible artefactual lowering in individuals with high plasma concentration of ascorbic acid. Clin. Chim. Acta 239, 185-190.
10. Berry EM (1992): The effects of nutrients on lipoprotein susceptibility to oxidation. Curr. Opin. Lipidol. 3, 5-11.
11. Bjorkhem I, Henrikksson-Freyschuss A, Breuer O, Diczfalusy U, Berglund L & Jenriksson P (1991). The antioxidant butylated hydroxytoluene protects against atherosclerosis. Artertioscler. Thromb. 11, 15-22.
12. Blann A, Midgely H, Burrows G, Maxwell S, Utting S, Davies M, Waite M & McCollum C (1993): Free radicals, antioxidants and endothelial cell damage after percutaneous transluminal coronary angioplasty. Coron. Art. Dis. 4, 905-910.
13. Block G (1991): Vitamin C and cancer prevention: the epidemiologic evidence. Am. J. Clin. Nutr. 53, 270S-2S2S.
14. Bolli R (1990): Mechanism of myocardial 'stunning'. Circulation 82, 723-738.
15. Borg DC (1993): Oxygen free radicals and tissue injury. In Oxygen Free Radicals in Tissue Damage, eds M Tarr & F. Samson, pp. 12-55. Boston: Birkhauser.
16. Bowry VW, Stanley KK & Stocker R (1992): High density lipoprotein is the major carrier of lipid hydroperoxides in human blood plasma from fasting donors. Proc. Natl Acad. Sci. USA 89, 10316-10320.
17. Brown KM, Morrice PC & Duthie GG (1994): Vitamin E supplementation suppresses indexes of lipid peroxidation and platelet counts in blood of smokers and nonsmokers but plasma lipoprotein concentrations remain unchanged. Am. J. Clin. Nutr. 60, 383-387.
18. Brown MS & Goldstein JL (1986): A receptor-mediated pathway for cholesterol homeostasis. Science 232, 34-47.
19. Bulkley GB (1994): Reactive oxygen metabolites and reperfusion injury: aberrant triggering of reticuloendothelial function. Lancet 344, 934-936.
20. Bunker VW (1992): Free radicals, antioxidants and ageing. Med. Lab. Sci. 49, 299-312.
21. Burton GW, Wronska U, Stone L, Foster DO & Ingold KU (1990): Biokinetics of dietary RRR-alpha-tocopherol in the male guinea pig at three dietary levels of vitamin C and two Levels of vitamin E. Evidence that vitamin C does not 'spare' vitamin E in vivo. Lipids 25, 199-210.
22. Carcelain G, David F, Lepage S, Bonnefont-Rousselot D, Delattre J, Legrand A, Peynet J & Troupel S (1992): Simple method for quantifying alpha tocopherol in low density- and very low density-lipoproteins and in high density lipoproteins. Clin. Chem. 38, 1792-1795.
23. Cerutti P, Fridovich I & McCord JM, eds (1988): OxyRadicals in Molecular Biology and Pathology. New York: Alan R. Liss.
24. Cerutti PA (1994): Oxy-radicals and cancer. Lancet 344, 862-863.
25. Chait A & Heinecke JW (1994): Lipoprotein modification: cellular mechanisms. Curr. Open. Lipidol. 5, 365-370.
26. Chatterjee S (1992): Role of oxidised human plasma low density lipoproteins in atherosclerosis: effects on smooth muscle cell proliferation. Molec. Cell. Biochem. 111, 143-147.
27. Cheeseman KH & Slater TF (1993): Free Radicals in Medicine. Br. Med. Bull. 49, 479-724.
28. Chinco S, Smith C, Marchant C, Mitchinson MJ & Halliwell B (1993): Lipid peroxidation in hyperlipidaemic patients; a study of plasma using an HPLC-based thiobarbituric acid test. Free Rod. Res. Commun. 19, 51-57.
29. Chow CK, Changchit C, Bridges RB, Rehn SR, Humble J & Turbek J (1989): Lower levels of vitamin C and carotenes in plasma of cigarette smokers. Am. J. Pub. Hlth 79, 158-162.
30. Clausen J, Nielsen SA & Kristensen M (1989): Biochemical and clinical effects of an antioxidant supplementation of geriatric patients. Biol. Trace Elem. Res. 20, 135-151.
31. Cloarec MJ, Perdriset GM, Lamberdiere FA, Colas-Belcour JF, Sauzieres JP, Neufeld HN & Goldbourt U (1987): Alpha tocopherol: effect on plasma lipoproteins in hypercholesterolaemic patients. Isr J. Med. Sci. 23, 869-872.
32. Comstock GW, Helzlsouer KJ & Bush TL (1991): Prediagnostic serum levels of carotenoids and vitamin E as related to subsequent cancer in Washington Country, Maryland. Am. J. Clin. Nutr. 53, 260S-264S.
33. Conti M, Morand PC, Levillain P & Lemonnier A (1991): Improved fluorimetric determination of malonaldehyde. Clin. Chem. 37, 1273-1275.
34. Coughlan JG, Flitter WD, Holley AE, Norell M, Mitchell AG, Ilsley CD & Slater TF (1991): Detection of free radicals and cholesterol hydroperoxides in blood taken from the coronary sinus of man during percutaneous transluminal coronary angioplasty. Free Rad. Res. Commun. 14, 409-417.
35. Croft KD, Dimmitt SB, Moulton C & Beilin LJ (1992): Low density lipoprotein composition and oxidisability in coronary disease - apparent favourable effect of beta blockers. Atherosclerosis 97, 123-130.
36. Croft KD, Williams P, Dimmitt S, Abu-Amsha R & Beilin LJ (1995): Oxidation of low density lipoproteins: effect of antioxidant content, fatty acid composition and intrinsic phospholipase activity on susceptibility to metal ion-induced oxidation. Biochim. Biophys. Acta 1254, 250-256.
37. Cutler RC (1991): Antioxidants and aging. Am. J. Cl. Nutr. 53, 373S-379S.
38. Davies MB (1991): Vitamin C: Its Chemistry and Biochemistry Cambridge: Royal Society of Chemistry.
39. Department of Health (1991): Dietary reference values for food energy and nutrients for the United Kingdom. Dep. Hlth Soc. Subj. No. 41. London: DHSS.
40. Di Masco P, Murphy MB & Sies H (1991): Antioxidant defense systems: the role of carotenoids, tocopherols and thiols. Am. J. Clin. Nutr 53, 194S-200S.
41. Dieber-Rotheneder M, Puhl H, Waeg G, Striegl G & Esterbauer H (1991): Effect of oral supplementation with d-alpha-tocopherol on the vitamin E content of human low density lipoprotein and resistance to oxidation. J. Lipid Res. 32, 1325-1332.
42. Diplock AT (1985): Fat Soluble Vitamins: Their Biochemistry and Applications. London: Heinemann.
43. Duthie GG (1993): Lipid peroxidation. Eur. J. Clin. Nutr. 47, 759-764.
44. Elinder LS & Walldius G (1994): Antioxidants and atherosclerosis progression: unresolved questions. Curr. Opin. Lipidol. 5, 265-268.
45. Emerit I & Chance B (1992): Free Radicals and Aging. Boston: Birkhauser.
46. Emerit I (1994): Reactive oxygen species, chromosome mutation and cancer: possible role of clastogenic factors in carcinogenesis. Free Rad. Biol. Med. 16, 99-109.
47. Espinosa-Mansilla A & Salina F (1994): Kinetic study of the malonaldehyde-azulene reaction determination of malonaldehyde in human plasma. Anal. Biochem 222, 396-403.
48. Esterbauer H & Jurgens G (1993): Mechanistic and genetic aspects of susceptibility of LDL to oxidation. Curr Opin. Lipidol. 4, 114-124.
49. Esterbauer H, Dieber-Rotheneder M, Waeg G, Striegl G & Jurgens G (1990): Biochemical, structural and functional properties of oxidised low-density lipoprotein. Chem. Res. Toxicol. 3, 77-92.
50. Esterbauer H, Gebicki J, Puhl H & Jurgens G (1992): The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Rad. Biol & Med 13, 341-390.
51. Esterbauer H, Puhl H, Dieber-Rotheneder M, Waeg G & Rabi H (1991 a): Effect of antioxidants on oxidative modification of LDL. Ann. Med. 23, 573-581.
52. Esterbauer H, Schaur RJ & Zollner H (1991b): Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Rad. Biol. Med. 11, 81-128.
53. Esterbauer H, Striegal G, Puhl H & Rotheneder M (1989): Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Rad. Res. Commun. 6, 67-75.
54. Ferns GAA, Konneh M & Anggard EE (1993): Vitamin E: the evidence for an anti-atherogenic role. Artery 20, 671-694.
55. Ferrari R, Ceconi C, Curello S, Cargnoni A, Pasini E, De Giuli F & Albertini A (1991): Role of oxygen free radicals in ischemic and reperfused myocardium. Am. J. Clin. Nutr. 53, 215S-222S.
56. Frankel EN, German JB & Davis PA (1992): Headspace gas chromatography to determine human LDL oxidation. Lipids 27, 1047-1105
57. Frankel EN, Kanner J, German JB, Parks E & Kinsella JE (1993): Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine Lancet 341, 454-457.
58. Fraser GE (1994): Diet and coronary heart disease: beyond dietary fats and low-density lipoprotein cholesterol. Am. J. Clin. Nutr. 59, 1117S-1123S.
59. Frei B, England L & Ames BN (1989): Ascorbate is an outstanding antioxidant in human blood plasma. Proc. Natl Acad. Sci. USA 86, 6377-6381.
60. Frei B & Gaziano JM (1993): Content of antioxidants, preformed lipid hydroperoxides and cholesterol as predictors of the susceptibility of human LDL to metal ion-dependent and -independent oxidation. J. Lipid Res. 34, 2135-2145.
61. Frei B, Kim MC & Ames BN (1990): Ubiquinol-10 is an effective lipid-soluble antioxidant at physiological concentrations. Proc. Natl Acad. Sci. 87, 4879-4883.
62. Frei B, Stocker R & Ames BM (1988a): Antioxidant defenses and lipid peroxidation in human blood plasma. Proc. Natl Acad. Sci. USA 85, 9748-9752.
63. Frei B. Yamamoto Y, Niclas D & Ames BN (1988b): Evaluation of an isoluminol chemiluminescence assay for the detection of hydroperoxide in human blood plasma. Anal. Biochem. 175, 120-130.
64. Frick AH, Manninen V, Huttunen JK, Heinonen OP, Tenkanen L & Manttari M (1990): HDL-cholesterol as a risk factor in coronary heart disease; an update of the Helsinki heart study. Drugs 40, 7-12.
65. Fuster V, Badimon L, Badimon JJ & Cheesebro JH (1992): The pathogenesis of coronary artery disease and the acute coronary syndromes. N. Engl. J. Med. 326, 242-250.
66. Garry PJ, Vanderjagt DJ & Hunt WC (1987): Ascorbic acid intakes and plasma levels in healthy elderly. Ann. NY Acad. Sci. 498, 90-99.
67. Gaziano JM & Hennekens CH (1992): Vitamin antioxidants and cardiovascular disease. Curr. Opin. Lipid. 3, 291-294.
68. Gey KF (1990): Lipids, lipoproteins and antioxidants in cardiovascular disease. Biochem Soc. Trans. 18, 1041-1045.
69. Gey KF & Puska P (1989): Plasma vitamins E and A inversely correlated to mortality from ischemic heart disease in cross-cultural epidemiology. Ann. NY Acad. Sci. 570, 268-282.
70. Gey KF, Brubacher GB & Stahelin HB (1987): Plasma levels of antioxidant vitamins in relation to ischaemic heart disease and cancer. Am. J. Clin. Nutr. 45, 1368-1377.
71. Gey KF, Moser UK, Jordan P, Stahelin HB, Eichholzer M & Ludin E (1993): Increased risk of cardiovascular disease at suboptimal plasma concentrations of essential antioxidants: an epidemiological update with special attention to carotene and vitamin C. Am. J. Clin. Nutr. 57, 787S-797S.
72. Ghiselli A, Serafini M, Maiani G, Azzxini E & Ferro-Luzzi A (1995): A fluorescence-based method for measuring total plasma antioxidant capacity. Free Rad. Biol. Med. 18, 29-36.
73. Ginter E (1978): Marginal vitamin C deficiency, lipid metabolism and atherogenesis. Adv. Lipid Res. 16, 167-170.
74. Goldstein JL, Ho YK, Basu SK & Brown MS (1979) Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc. Natl Acad. Sci. USA 76, 333-337.
75. Gopaul NK, Nourooz-Zadeh J, Mallet AI & Anggard EE (1994): Formation of F2-isoprostanes during aortic endothelial cell-mediated oxidation of low density lipoprotein. FEBS Lett. 348, 297-300.
76. Gorog P (1992): Neutrophil-oxidised low density lipoprotein: generationin and clearance from the plasma. Int. J. Exp. Path. 73, 485-490.
77. Greenberg ER, Baron JA, Tosteson TD, Freeman D, Beck GJ, Bond JH, Colacchio TA, Coller JA, Frankl HD, Haile RW, Mandel JS, Nierenberg DW, Rothstein R, Snover DC, Stevens MM, Summer RW & Van Stolk RU (1994): A clinical trial of antioxidant vitamins to prevent colorectal adenoma, N. Engl. J. Med. 331, 141-147.
78. Grundy SM (1995): Role of low-density lipoproteins in atherogenesis and development of coronary heart disease. Clin. Chem. 41, 139-146.
79. Gutteridge JMC (1986): Aspects to consider when detecting and measuring lipid peroxidation. Free Rad. Res. Commun. 1, 173-184.
80. Gutteridge JMC (1994): Antioxidants, nutritional supplements and life-threatening diseases. Br. J. Biomed. Sci. 51, 288-295.
81. Hallfrisch J, Singh VN, Muller DC, Baldwin H, Bannon ME & Andres R (1994): High plasma vitamin C associated with high plasma HDL- and HDL2 cholesterol. Am. J. Clin. Nutr. 60, 100-105.
82. Halliwell B (1990): How to characterize a biological antioxidant. Free Rad. Res. Commun. 9, 1-32.
83. Halliwell B (1994): Free radicals, antioxidants and human disease: curiosity, cause or consequence? Lancet 3244, 721-724.
84. Halliwell B & Aruoma OI (1993): DNA and Free Radicals. Chichester: Ellis Horwood.
85. Halliwell B & Gutteridge JMC (1989): Free Radicals in Biology and Medicine. Oxford: Oxford University Press.
86. Halliwell B & Gutteridge JMC (1990): The antioxidants of extracellular fluids. Arch. Biochem. Biophys. 280, 1-8.
87. Halliwell B & Gutteridge JMC (1995): The definition and measurement of antioxidants in biological systems. Free Rad. Biol. Med. 18, 125-126.
88. Hamsten A (1993): Lipids as a coronary risk factor: analysis of hyperlipidaemias. Postgrad Med. J. 69, S8-S11.
89. Harats D, Ben-Naim M, Dabach Y, Hollander G, Havivi E, Stein O & Stein Y (1990): Effect of vitamin C and E supplementation on susceptibility of plasma lipoproteins to peroxidation induced by acute smoking. Atherosclerosis 85, 47-54.
90. Harman D (1956): Aging: a theory based on free radical and radiation chemistry. Gerontology 11, 298-300.
91. Hazell LJ, Van Den Berg JJ & Stocker R (1994): Oxidation of low density lipoprotein by hypochlorite causes aggregation that is mediated by modification of lysine residues rather than lipid oxidation. Biochem. J. 302, 297-304.
92. Heinecke JW, Li W, Mueller DM, Bohrer A & Turk J (1994): Cholesterol chlorohydrin synthesis by the myeloperoxidase-hydrogen peroxide-chloride system: potential markers for lipoproteins oxidatively damaged by phagocytes. Biochemistry 33, 10127-10136.
93. Hemila H (1992): Vitamin C and plasma cholesterol. Crit. Rev. Food Sci. Nutr. 32, 33-57.
94. Hennekens CH, Buring JE & Peto R (1994): Antioxidant vitamins - benefits not yet proved. N. Engl. J. Med. 330, 1080-1081.
95. Hennekens CH & Gaziano JM (1993): Antioxidants and heart disease: epidemiology and clinical evidence. Clin. Cardiol. 16, 110-115.
96. Hennig B & Alvarado A (1993): Nutrition and endothelial cell integrity: implications in atherosclerosis. Progr. Food Nutr. Sci. 17, 119-157.
97. Hogg N, Darley-Usmar VM, Graham A & Monacada S (1993): Peroxynitrite and atherosclerosis. Biochem. Soc. Proc. 21, 358-362.
98. Ikatsu H, Nakahima T, Murayama N & Korenaga T (1992): Flow injection analysis for malondialdehyde in plasma with thiobarbituric acid reaction. Clin. Chem. 38, 2061-2065.
99. Illingworth DR (1993): The potential role of antioxidants in the prevention of atherosclerosis. J. Nutr. Sci. Vitaminol. 39, S43-S47.
100. Ingold KU, Webb AC, Witter D, Burton GW, Metcalf TA & Muller DPR (1987): Vitamin E remains the major lipid-soluble, chain breaking antioxidant in human plasma even in individuals suffering severe vitamin E deficiency. Arch. Biochem. Biophys. 259, 224-225.
101. International Taskforce for Prevention of Coronary Heart Disease (1992): Prevention of coronary heart disease: scientific background and clinical guidelines. Nutr. Metab. Cardiovasc. Dis. 2, 113-156.
102. Jacob RA, Kelley DS, Pianalto FSt, Swendseid ME, Henning S, Zhang JZ, Ames BN, Fraga CG & Peters JH (1991): Immunocompetence and oxidant defense during ascorbate depiction of healthy men. Am. J. Clin. Nutr. 54, 1302S-1309S.
103. Jacques PF (1992): Relationship of vitamin C status to cholesterol and blood pressure. Ann. NY Acad. Sci. 669, 205-213.
104. Janero DR (1991): Therapeutic potential of vitamin E in the pathogenesis of spontaneous atherosclerosis. Free Rad. Biol. Med. 11, 129-144.
105. Jenner P (1994): Oxidative damage in neurogenerative disease. Lancet 344, 796-798.
106. Jessup W, Dean RT & Gebicki JN (1994): Iodometric determination of hydroperoxides in lipids and proteins. In Methods in Enzymology, Vol. 233, part C: Oxygen Radicals in Biological Systems, ed. L. Packer, pp. 284-303. San Diego: Academic Press.
107. Jialal I & Fuller CJ (1993): Oxidized LDL and antioxidants. Clin. Cardiol. 16, 16-19.
108. Jialal I, Vega GL & Grundy SM (1990): Physiologic levels of ascorbate inhibit oxidative modification of low density lipoprotein. Atherosclerosis 82, 185-191.
109. 2+ in the presence of xylenol orange. Comparison with the TBA assay and an iodometric assay. Lipids 26, 853-856.
110. Kagan VE, Serbinova EA, Forte T, Scita G & Packer L (1992): Recycling of vitamin E in human low density lipoproteins. J. Lipid Res. 33, 385-397.
111. Kaneko T, Nakano S & Matsuo M (1991): Protective effect of vitamin E on linoleic acid hydroperoxide-induced injury to human endothelial cells. Lipids 26, 345-348.
112. Kleinveld HA, Hak-Lemmers HLM, Stalenhoef AFH & Demacker PNM (1992): Improved measurement of low density-lipoprotein susceptibility to copper-induced oxidation: application of a short procedure for isolating low-density lipoprotein. Clin. Chem. 38, 2066-2072.
113. Kleinveld HA, Naber AHJ, Stalenhoef AFH & Demacker PNM (1993): Oxidation resistance, oxidation rate, and extent of oxidation of human low-density lipoprotein depend on the ratio of oleic acid content to linoleic acid content: studies in vitamin E deficient subjects. Free Rad. Biol. Med. 15, 273-280.
114. Kneepkens CMF, Lepage G & Roy CC (1994): The potential of the hydrocarbon breath test as a measure of lipid peroxidation. Free Rad. Biol. Med 17, 127-160.
115. Knight JA (1995): Diseases related to oxygen-derived free radicals. Ann. Clin. Lab. Sci. 25, 1111-1121.
116. Knight JA, Pieper RK & McClellan L (1988): Specificity of the thiobarbituric acid reaction; its use in studies of lipid peroxidation. Clin. Chem. 34, 2433-2438.
117. Knight JA, Smith SE, Kinder VE & Anstall HB (1987): Reference intervals for plasma lipoperoxides: age- sex-and specimen-related variations. Clin. Chem. 33, 2289-2291.
118. Krebs HA (1953): The Sheffield experiment on the vitamin C requirement of adults. Proc. Nutr. Soc. 12, 237-246.
119. Lang J, Celotto C & Esterbauer H (1985): Quantitative determination of the lipid peroxidation product 4-hydroxynonenal by high-performance liquid chromatography. Anal. Biochem. 150, 369-378.
120. Levine M & Hartzell W (1987): Ascorbic acid: the concept of optimum requirements. Ann NY Acad. Sci. 498, 424-444.
121. Levine M, Cantilena CC & Dhariwal KR (1993): In situ kinetics and ascorbic acid requirements. Wld Rev. Nutr. Diet. 72, 114-127.
122. Ma YS, Stone WL & LeClair IO (1994). The effects of vitamin C and urate on the oxidation kinetics of human low-density lipoprotein. Proc. Soc. Exp. Biol. Med. 206, 53-59.
123. Maggi E, Finardi G, Poli M, Bollati P, Fillipono M, Stefano PL, Paolini G, Grossi A, Clot P, Albano E & Bellomo G (1993): Specificity of autoantibodies against oxidised LDL as an additional marker for atherosclerotic risk. Coron. Art. Dis. 4, 1119-1122.
124. Masarei JRL, Kiiveri HT & Stanton K (1986): Risk factors for cardiovascular disease in a diabetic population. Pathology 18, 89-93.
125. Maxwell SRJ (1993): Can antioxidants prevent ischaemic heart disease? J. Clin. Pharmacol. Therapeut. 18, 85-95.
126. McCord JM (1993): Human disease, free radicals and the oxidant/antioxidant balance. Clin. Biochem. 26, 351-357.
127. Meister A (1992): Commentary on the antioxidant effects of ascorbic acid and glutathione. Biochem. Pharmacol. 44, 1905-1915.
128. Mera SL (1994): Diet and disease. Br. J. Biomed, Sci. 51, 189-206.
129. Meydani M (1995): Vitamin E. Lancet 345, 170-175.
130. Miller NE (1990): HDL metabolism and its role in lipid transport. Eur. Heart J. 11, H1-H3.
131. Miller NJ, Rice-Evans C, Davies MJ, Gopinathan V & Milner A (1993): A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates. Clin. Sci. 84, 407-412.
132. Morel DW, De La Llera-Moya M & Friday KE (1994): Treatment of cholesterol-fed rabbits with dietary vitamins E and C inhibits lipoprotein oxidation but not development of atherosclerosis. J. Nutr. 124, 2123-2130.
133. Muckle TJ & Nazir DJ (1989): Variation in human high density lipoprotein response to oral vitamin E dosage. Am. J. Clin. Pathol. 91, 165-171.
134. Mulholland CW & Strain JJ (1993): Total radical-trapping antioxidant potential (TRAP) of plasma: effects of supplementation of young healthy volunteers with large doses of alpha tocopherol and ascorbic acid. Int. J. Vit. Nutr. Res. 63, 27-30.
135. Nagelkerke JF, Havekes L, Van Hinsbergh VWM & Van Berkel TJC (1984): In vivo catabolism of biologically modified LDL. Arteriosclerosis 4, 256-264.
136. Naidoo R & Knapp ML (1992): Studies of lipid peroxidation products in cerebrospinal fluid and serum in multiple sclerosis and other conditions. Clin. Chem. 38, 2449-2454.
137. Nair V, Cooper CS, Vietti DE & Turner GA (1986): The chemistry of lipid peroxidation metabolites: crosslinking reactions of malondialdehyde. Lipids 21, 6-10.
138. Naito C, Kawamura M & Yamamoto Y (1993): Lipid peroxides as the initiating factor of atherosclerosis. Ann. NY Acad. Sci. 676, 27-45.
139. Nicki E (1987): Interaction of ascorbic acid and alpha tocopherol. Ann. NY Acad. Sci. 498, 186-199.
140. Ohrvall M, Tengblad S, Ekstrand B, Siegbahn A & Vessby B (1994): Malondialdehyde concentration in plasma is inversely correlated to the proportion of linoleic acid in serum lipoprotein lipids. Atherosclerosis 108, 103-110.
141. Packer L (1992a): New horizons in vitamin E research - the vitamin E cycle, biochemistry and clinical applications. In Lipid Soluble Antioxidams: Biochemistry and Clinical Applications, eds ASH Ong & L Packer, pp 1-16. Basel: Birkhauser.
142. Packer L (1992b): Interactions among antioxidants in health and disease: vitamin E and its redox cycle. Proc. Soc. Exp. Biol. 200, 271-276.
143. Packer L (1994): Methods in Enzymology, Vol. 233, part C: Oxygen Radicals in Biological Systems. San Diego: Academic Press.
144. Packer L & Glazer AN (1990): Methods in Enzymology, Vol. 186, part B: Oxygen Radicals and Antioxidants. San Diego: Academic Press.
145. Parthasarathy S, Barnett J & Fong LG (1989): High-density lipoprotein inhibits the oxidative modification of low-density lipoprotein. Biochim. Biophys. Acta 1044, 275-283.
146. Parthasarathy S, Khoo JC, Miller E, Barnett HJ, Witzum JL & Steinberg D (1990): Low density lipoprotein rich in oleic acid is protected against oxidative modification: implications for dietary prevention of atherosclerosis. Proc. Natl Acad. Sci. USA 87, 3894-3898.
147. Parthasarathy S, Steinberg D & Witzum JL (1992): The role of oxidised low-density lipoproteins in the pathogenesis of atherosclerosis. Ann. Rev. Med. 43, 219-225.
148. Plachta H, Bartnikowska E & Obara A (1992): Lipid peroxides in blood from patients with atherosclerosis of coronary and peripheral arteries. Clin. Chim. Acta 211, 101-112.
149. Popov IN & Lewin G (1994): Photochemiluminescent detection of antiradical activity: II testing of nonenzymic water-soluble antioxidants. Free Rad. Biol. Med. 17, 267-271.
150. Prasad KN & Edwards-Prasad J (1992): Vitamin E and cancer prevention: recent advances and future potentials. J. Am. Coll. Nutr. 11, 487-500.
151. Prasad K & Kalra J (1993): Oxygen free radicals and hypercholesierolemic atherosclerosis: effect of vitamin E. Am. Heart J. 125, 958-973.
152. Pré J (1993): Plasma measurement of xylenol orange reactive substances; normal values in non-smokers and smokers. Med. Sci. Res. 21, 185-186.
153. Pré J, Le Floch A, Vassy R & Le Noble C (1989): Increased plasma level of fluorescent lipid-peroxidation products in cigarette smokers. Med. Sci. Res. 17, 1029-1030.
154. Princen HMG, van Duyvenvoorde W, Buytenhek R, van der Larse A, van Poppel G, Gevers Leuven JA & van Hinsbergh VWM (1995): Supplementation with low doses of vitamin E protects LDL from lipid peroxidation in men and women. Arterioscler. Thromb. Vasc. Biol. 15, 325-333.
155. Raal FJ, Areias AJ, Pilcher GJ, Joffe BI & Seftel HC (1994): Lack of effect of high dose vitamin E on xanthoma regression in homozygous familial hypercholesterolamia. Atherosclerosis 107, 213-219.
156. Reaven PD, Grasse BJ & Tribble DL (1994): Effects of linoleate-enriched diets in combination with alpha tocopherol on the susceptibility of LDL and LDL subfractions to oxidative modification in humans. Arterioscler. Thromb. 14, 557-566.
157. Regnstrom J & Nilsson J (1994): Lipid oxidation and inflammation-induced intimal fibrosis in coronary heart disease. J. Lab. Clin. Med. 124, 168.
158. Retsky KL, Freeman MW & Frei B (1993): Ascorbic acid oxidation product(s) protect human low density lipoprotein against atherogenic modification. J. Biol. Chem. 268, 1304-1309.
159. Rice-Evans CA & Diplock AT (1993): Current status of antioxidant therapy. Free Rad. Biol. Med. 15, 77-96.
160. Rice-Evans CA, Diplock AT & Symons MCR (1991): Laboratory Techniques in Biochemistry and Molecular Biology, Vol. 22: Techniques in Free Radical Research. London: Elsevier.
161. Richard MJ, Portal B, Meo J, Coudray C, Hadjian A & Favier A (1992): Malondialdehyde kit evaluated for determining plasma and lipoprotein fractions that react with thiobarbituric acid. Clin. Chem. 38, 710-709.
162. Riemersma RA (1994): Epidemiology and the role of antioxidants in preventing coronary heart disease; a brief overview. Proc. Nutr. Soc. 57, 787S-997S.
163. Riemersma RA, Wood DA, MacIntyre CCA, Elton RA, Gey KF & Oliver NF (1991): Risk of angina pectoris and plasma concentrations of vitamins A, C, E and carotene. Lancet 53, 1-9.
164. Rifkind BM (1990): High density lipoprotein and coronary heart disease: survey of the evidence. Am. J. Cardiol. 66, 3A-6A.
165. Rimm EB, Stampfer MJ, Ascherio A, Giovannucci E, Colditz GA & Willett WC (1993): Vitamin E consumption and risk of coronary heart disease in men. N. Engl. J. Med. 328, 1450-1456.
166. Rifici VA & Khachadurian AK (1992): The inhibition of low density lipoprotein oxidation by 17 beta oestradiol. Metabolism 41, 1110-1114.
167. Rivers JM (1987): Safety of high level vitamin C ingestion. Ann. NY Acad. Sci. 498, 445-454.
168. Roberts LJ & Morrow JD (1994): Isoprostanes: novel markers of endogenous lipid peroxidation and potential mediators of oxidant injury. Ann. NY Acad. Sci. 744, 237-242.
169. Roheim PS & Asztalos BF (1995): Clinical significance of lipoprotein size and risk for coronary atherosclerosis. Clin. Chem. 41, 147-152.
170. Ross R (1993): Atherosclerosis: current understanding of mechanisms and future strategies in therapy. Transplant. Proc. 25, 2041-2043.
171. Salonen JT, Yla-Herttuala S, Yamamoto R, Butler S, Korpela H, Salonen R, Nyyssonen K. Palinski W & Witzum JL (1992): Autoantibody against oxidised LDL and progression of carotid atherosclerosis. Lancet 339, 883-887.
172. Satoh K (1978): Serum lipid peroxide in cerebrovascular disorders determined by a new colourimetric method. Clin. Chim. Acta 90, 37-43.
173. Schafer L & Thorling EB (1990): Lipid peroxidation and antioxidant supplementation in old age. Scand. J. Clin. Invest. 50, 69-70.
174. Schorah CJ (1992): The transport of vitamin C and effects of disease. Proc. Nutr. Soc. 51, 189-198.
175. Schwartz JL, Antoniades DZ & Zhao S (1993): Molecular and biochemical reprogramming of oncogenesis through the activity of prooxidants and antioxidants. Ann. NY Acad. Sci. 686, 262-278.
176. Sevanian A & Hochstein P (1985): Mechanisms and consequences of lipid peroxidation in biological systems. Ann. Rev. Nutr. 5, 365-390.
177. Sevanian A, Davies KJA & Hochstein P (1991): Serum urate as an antioxidant for ascorbic acid. Am. J. Clin. Nutr. 54, 1129S-1134S.
178. Shafar J (1967): Rapid reversion of electrocardiographic abnormalities after treatment in two cases of scurvy. Lancet 2, 176.
179. Sharov VS, Kazamanov VA & Vladimirov YA (1989): Selective sensitisation of chemiluminescence resulted from lipid and oxygen radical reactions. Free Rad. Biol. Med 7, 237-242.
180. Shimasaki H, Hirai N & Ueta N (1988): Comparison of fluorescence characteristics of products of peroxidation of membrane phospholipids with those of products derived from reaction of malonaldehyde with glycine as a model of lipofuscin fluorescent substances. J. Biochem. 104, 761-766
181. Simon JA (1992): Vitamin C and cardiovascular disease: a review. J, Am. Coll. Nutr. 11, 107-125.
182. Sinclair AJ, Girling AJ, Gray L, Lunec J & Barnett AH (1992): An investigation of the relationship between free radical activity and vitamin C metabolism in elderly diabetic subjects with retinopathy. Gerontology 38, 268-274.
183. Smith D, O'Leary VJ & Darley-Usmar VM (1993): The role of alpha tocopherol as a peroxyl radical scavenger in human low density lipoprotein. Biochem. Pharmacol. 45, 2195-2201
184. Stampfer MJ, Hennekens CH, Manson JE, Colditz GA, Rosner B & Willett WC (1993): Vitamin E consumption and the risk of coronary heart disease in women. N. Engl. J. Med. 328, 1444-1449.
185. Steinberg D (1992): Antioxidants in the prevention of human atherosclerosis. Circulation 85, 2338-2344.
186. Steinberg D (1993): Antioxidant vitamins and coronary heart disease. N Engl. J. Med. 328, 1487-1489.
187. Steinberg D & Witzum JL (1990): Lipoproteins and atherogenesis; current concepts. J. Am. Med. Assoc. 264, 3047-3052.
188. Steinberg D, Parthasarathy S, Carew TE, Khoo JC & Witzum JL (1989): Beyond cholesterol; modifications of low-density lipoprotein that increase its atherogenicity. N. Engl. J. Med. 320, 915-924.
189. Stocker R (1994): Lipoprotein oxidation: mechanistic aspects, methodological aspects and clinical relevance. Curr. Opin. Lipidol. 5, 422-433.
190. Sullivan JL (1994): Antioxidant effects of iron depletion. Free Rad. Biol. Med. 17, 87.
191. Swain JA, Darley-Usmar V & Gutteridge JM (1994): Peroxynitrite releases copper from caeruloplasmin: implications for atherosclerosis. FEBS Lett. 342, 49-52.
192. Tarr M & Samson F (1993): Oxygen Free Radicals in Tissue Damage. Boston: Birkhauser.
193. The Alpha Tocopherol, Beta Carotene Cancer Prevention Study Group (1994): The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. .J. Engl. J. Med. 330, 1029-1035.
194. Tolonen M, Sarna S, Halme M, Tuominen SE, Westermarck T, Nordberg U, Keinonen M & Schrijver J (1988): Antioxidant supplementation decreases TBA reactants in serum of elderly. Biol. Trace Element Res. 17, 221-228.
195. Traber MG (1994): Determinants of plasma vitamin E concentrations. Free Rad. Biol. Med. 16, 229-239.
196. Tsuchida M, Miura T, Mizutani K & Aibara K (1985): Fluorescent substances in mouse and human sera as a parameter of in vivo lipid peroxidation. Biochim Biophys. Acta 834, 196-204.
197. Valstar E (1994): Nutrition and cancer: a review of the preventive and therapeutic abilities of single nutrients. J. Nutr. Med. 4, 179-198.
198. Van den Berg J & Winterbourne C (1994): Measurement of reaction products from hypochlorous acid and unsaturated lipids. In Methods in Enzymology, Vol. 233, part C: Oxygen Radicals in Biological Systems, ed. L Packer, pp. 639-649. San Diego: Academic Press.
199. Van der Vliet A, O'Neill CA, Halliwell B, Cross CE & Kaur H (1994): Aromatic hydroxylation and nitration of phenylalanine and tyrosine by peroxynitrite. Evidence for hydroxyl radical production from peroxynitrite. FEBS Lett. 339, 89-92.
200. VanderJagt DJ, Garry PJ & Bhagavan HN (1987): Ascorbic acid intake and plasma levels in healthy elderly people. Am J. Clin. Nutr. 46, 290-294.
201. Verlangieri AJ & Bush M (1992): Prevention and regression of atherosclerosis by alpha tocopherol. J. Am. Coll. Nutr. 11, 131-138.
202. Virella G, Virella I, Leman RB, Pryor MB & Lopes-Virella MF (1993): Anti-oxidised low-density lipoprotein antibodies in patients with coronary heart disease and normal healthy volunteers. Int. J. Clin. Lab. Res. 23, 95-101.
203. 3+-tetracyclin complex activates chemiluminescence accompanying lipid peroxidation in liposomes. Photobiochem. Photobiophys. 2, 279-284.
204. Wandzilak TR, D'Andre SD. Davis PA & Williams HE (1994): Effect of high dose vitamin C on urinary oxalate levels. J. Urol. 151, 834-837.
205. Wang YH, Dhariwal KR & Levine M (1992): Ascorbic acid bioavailability in humans. Ann. NY Acad. Sci 669, 383-386.
206. Wartanowicz M, Panczenko-Kresowska B, Ziemlanski S, Kowlaska M & Okolska G (1984): The effect of alpha tocopherol on the serum lipid peroxide level in elderly people. Ann. Nutr. Metab. 28, 186-191.
207. Wayner DDM, Burton GW, Ingold KU, Barclay LRC & Locke SJ (1987): The relative contributions of vitamin E, urate, ascorbate and proteins to the total peroxyl radical-trapping antioxidant activity of human blood plasma. Biochim. Biophys. Acta 924, 408-419.
208. Weisburger JH (1991): Nutritional approach to cancer prevention with emphasis on vitamins, antioxidants and carotenoids. Am. J. Clin. Nutr. 53, 226S-237S.
209. Weiss JN, Goldhaber JI & Sen Ji (1993): Oxygen free radicals in the pathophysiology of myocardial ischaemia/reperfusion. In Oxygen Free Radicals in Tissue Damage, eds M Tarr & F Samson, pp. 250-266. Boston: Birkhauser.
210. Wennmalm Å (1994): Endothelial nitric oxide and cardiovascular disease. J. Int. Med. 235, 317-327.
211. Whitehead TP, Robinson D, Allaway S, Syms J & Hale A (1995): Effect of red wine on the antioxidant capacity of serum. Clin. Chem. 41, 32-35.
212. Whitehead TP, Thorpe GHG & Maxwell SRJ (1992): Enhanced chemiluminescent assay for antioxidant capacity in biological fluids. Anal. Chim. Acta 266, 265-277.
213. Willis GC (1953): An experimental study of the intimal ground substance in atherosclerosis. Can. Med. Assoc. J. 17, 17-22.
214. Wolff SA (1994): Ferrous ion oxidation in presence of ferric ion indicator xylenol orange for measurement of hydroperoxides. In Methods in Enzymology, Vol. 233, part C: Oxygen Radicals in Biological Systems, ed. L Packer, pp. 182-189. San Diego: Academic Press.
215. Wong HY, Knight JA, Hopfer SM, Zaharia O, Leach CN Jr & Sunderman FW Jr (1987): Lipoperoxides in plasma as measured by liquid-chromatographic separation of malondialdehyde-thiobarbituric acid adduct. Clin. Chem. 33, 214-220.
216. Woodard DA & Limacher MC (1993): The impact of diet on coronary heart disease. Clin. Nutr. 77, 849-862.
217. World Health Organisation (1989): The WHO MONICA Project. Wld Health Stat. Q. 42, 27-149.
218. Yagi K (1982): Assay for serum lipid peroxide level and its clinical significance. In Lipid Peroxides in Biology and Medicine, ed. K Yagi, pp. 223-242. San Diego: Academic Press.
219. Yamamoto Y, Brodsky MH, Baker JC & Ames BN (1987): Detection and characterisation of lipid hydroperoxides at picomole levels by high performance liquid chromatography. Anal. Biochem. 160, 7-13.
220. Young SG & Parthasarathy S (1994): Why are low-density lipoproteins atherogenic? W. J. Med. 160, 153-164.
221. Yu BY (1994): Cellular defenses against damage from reactive oxygen species. Physiol. Rev. 74, 139-162.
222. Yue DK, McLennan S, Fisher E, Hefferman S, Capogreco C, Ross GR & Turtle JR (1989): Ascorbic acid metabolism and the polyol pathway in diabetes. Diabetes 38, 257-261.